About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Lung Cancer Screening Guidelines Released

by Anjali Aryamvally on October 29, 2017 at 11:15 AM
Font : A-A+

New Lung Cancer Screening Guidelines Released

Each year, deaths due to lung cancer outrun deaths caused by colon, breast and prostate cancers combined. Low-dose CT (LDCT) screening for lung cancer has become a standard practice mostly due to the results of the National Lung Cancer Screening Trial. As a widely used screening method, it is important that the benefits and risks of LDCT in clinical practice are continuously evaluated and updated.

Lung cancer experts and authors of the manuscript submitted to the journal CHEST -- Screening for Lung Cancer: CHEST Guideline and Expert Panel Report -- and will present the updated evidence to provide recommendations at CHEST 2017.

Advertisement


Key recommendations and shifts from previous guidelines include:

• For asymptomatic smokers and former smokers age 55 to 77 who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years, we suggest that annual screening with low-dose CT should be offered.
Advertisement

• For asymptomatic smokers and former smokers who do not meet the smoking and age criteria in Recommendation #1 but are deemed to be at high risk of having/developing lung cancer based on clinical risk prediction calculators, we suggest that low-dose CT screening should not be routinely performed.

• For individuals who have accumulated fewer than 30 pack-years of smoking or are younger than age 55 or older than age 77, or have quit smoking more than 15 years ago, and do not have a high risk of having/developing lung cancer based on clinical risk prediction calculators, we recommend that low-dose CT screening should not be performed.

• For individuals with comorbidities that adversely influence their ability to tolerate the evaluation of screen-detected findings, or tolerate treatment of an early stage screen-detected lung cancer, or that substantially limit their life expectancy, we recommend that low-dose CT screening should not be performed.

"This guideline differs from our previous guideline as we went beyond discussing harms and benefits," said Peter Mazzone, M.D., F.C.C.P., guideline chair. "We addressed implementation of low-dose CT screening, including who to screen, how to identify appropriate patients for screening, how to conduct a shared-decision-making visit, how to perform LDCT and how to manage abnormal findings."

"The potential benefit of cancer screening to reduce the number of cancer-related deaths must be balanced with potential harms of screening," said Gerard Silvestri, M.D., F.C.C.P., guideline panelist and CHEST immediate past president. "Current evidence suggests that even within groups at high risk of developing a cancer, only a small fraction of those screened will benefit, while everyone screened is exposed to potential harms including physical and psychosocial consequences of identifying and subsequently evaluating a screen-detected nodule, radiation exposure, overdiagnosis and overtreatment. For this reason, our recommendations for screening have evolved to be even more selective and specifically target those highest risk populations. The evidence currently does not support widespread adoption of lung cancer screening outside of those patients described in our recommendations."

Further results from the guidelines will be shared at the CHEST Annual Meeting 2017 in Toronto. The session will also be live streamed on Facebook Live by CHEST. The recommendation summary along with remarks for each recommendation and abstract can be viewed on the website of the American College of Chest Physicians, and forthcoming complete manuscript will be published in the journal CHEST.

ABOUT CHEST 2017

CHEST 2017 is the 83rd annual meeting of the American College of Chest Physicians, held in Toronto, Ontario. The American College of Chest Physicians, publisher of the journal CHEST®, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research and team-based care. Its mission is to champion the prevention, diagnosis and treatment of chest diseases through education, communication and research. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
Fermented Skin Care
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Lung Biopsy Lung Cancer Cancer and Homeopathy Cancer Facts Asbestosis Cancer Tattoos A Body Art Pneumoconiosis Smoking among Women Silicosis 

Recommended Reading
Low-dose CT Scan More Effective In Treating AS Patients
A sensitive method of assessing the Ankylosing Spondylitis (AS) disease progression without ......
Lung Cancer Screening With Low-Dose CT Could Be Cost Effective, Says Dartmouth Study
Dartmouth scientists said that the lung cancer screening in the National Lung Screening Trial ......
Low-Dose CT Screening Can Wrongly Or Overtly Diagnose Probability of Lung Cancer: NLST Data
Researchers recently got an opportunity to investigate the probability that a cancer detected with ....
Saving Lives Using Low-dose CT Screening for Lung Cancer
Shown to significantly reduce mortality rates among people at high risk of developing the disease .....
Asbestosis
Asbestosis is a chronic inflammatory lung disease that occurs due to long term exposure to asbestos ...
Lung Biopsy
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy...
Lung Cancer
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with ...
Pneumoconiosis
Pneumoconiosis is a group of lung diseases caused by inhaled dust particles. It causes inflammation ...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...
Smoking among Women
Tobacco use in women is on the rise. The health risks of tobacco are far too many has never done a w...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)